The current status of emergency contraception use in reproductive-aged Korean women: a population-based internet survey.
anxiety
counseling
emergency contraception
reason
reproductive-aged women
survey
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2023
2023
Historique:
received:
21
03
2023
accepted:
24
05
2023
medline:
28
6
2023
pubmed:
26
6
2023
entrez:
26
6
2023
Statut:
epublish
Résumé
This study was conducted to assess the current status of emergency contraception (EC) use in reproductive-aged Korean women. This study utilized a population-based, cross-sectional online survey using a self-completed questionnaire in women aged 20-44 years who had visited a clinic in the previous six months for contraception counseling. Reason for use, anxiety, and counseling for further contraception at EC use were analyzed according to age, history of childbirth, and contraceptive failure in EC users. Among 1,011 respondents, 461 (45.6%) had experience with EC use. Younger age, need for EC due to inadequate contraception, and high anxiety were highly prevalent among EC users. However, women in the 20s were less likely to get counseling for further contraception at EC use. Additionally, the proportions of women who used EC due to inadequate contraception during sexual intercourse and who experienced high anxiety were lower among women who had a history of childbirth. Women who had a history of contraceptive failure worried less about EC use. Our findings offer insight for developing and improving individualized strategies for appropriate contraception, especially in young Korean EC users.
Identifiants
pubmed: 37361519
doi: 10.3389/fendo.2023.1191096
pmc: PMC10285287
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1191096Informations de copyright
Copyright © 2023 Lee, Kim, Choi and Lee.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Lancet Glob Health. 2018 Apr;6(4):e380-e389
pubmed: 29519649
Reprod Health. 2015 Sep 22;12:91
pubmed: 26395172
Yonsei Med J. 2022 Nov;63(11):999-1006
pubmed: 36303308
Arch Gynecol Obstet. 2017 Mar;295(3):651-660
pubmed: 27896473
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):145
pubmed: 33507891
Matern Child Health J. 2017 Nov;21(11):2132-2139
pubmed: 28699094
Eur J Contracept Reprod Health Care. 2018 Jun;23(3):183-193
pubmed: 29785864
Eur J Contracept Reprod Health Care. 2016 Aug;21(4):310-7
pubmed: 27259660
Int J Nurs Stud. 2008 May;45(5):775-83
pubmed: 17349645
Womens Health Issues. 2012 May-Jun;22(3):e311-8
pubmed: 22555219
Eur J Contracept Reprod Health Care. 2014 Apr;19(2):93-101
pubmed: 24392826
Gynecol Obstet Invest. 2010;70(3):154-9
pubmed: 20558988
Obstet Gynecol. 2015 Apr;125(4):904-911
pubmed: 25751211
Hum Reprod. 2015 Apr;30(4):751-60
pubmed: 25678571
Contraception. 2021 Nov;104(5):553-555
pubmed: 34139152
Pharmacy (Basel). 2020 Nov 20;8(4):
pubmed: 33233848
Contracept X. 2021 May 10;3:100065
pubmed: 34136798
BMJ Sex Reprod Health. 2020 Oct;46(4):254-269
pubmed: 31826883
N Engl J Med. 2016 Mar 3;374(9):843-52
pubmed: 26962904
Obstet Gynecol Sci. 2019 May;62(3):173-178
pubmed: 31139593
Eur J Contracept Reprod Health Care. 2008 Dec;13(4):362-75
pubmed: 19170278
Contraception. 2021 Oct;104(4):401-405
pubmed: 34224695
Cochrane Database Syst Rev. 2019 Jan 20;1:CD001324
pubmed: 30661244
Contracept X. 2021 Feb 08;3:100061
pubmed: 33718861
Rev Saude Publica. 2021 Nov 22;55:74
pubmed: 34816977
BJOG. 2017 Dec;124(13):1948-1956
pubmed: 28658565